NCT00834639View on ClinicalTrials.gov

Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

divalproex sodium

delayed-release 500 mg tablet

DRUG

Depakote®

delayed-release 500 mg tablet

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834639 - Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter